Dashboard
Analysis
Charting
Screener
Resources
Settings
NYSE-JNJ
Mar '15
Jan '17
Sep '18
Jun '20
Apr '22
Dec '23
Sep '25
Trailing Valuation
Stock Price
179.7
152.4
163.7
145.1
161.4
146.2
Total Shares Outstanding
2,406.2
2,406.8
2,405.6
2,406.9
2,407.3
2,407
Market Cap
432,417.3
366,817.2
393,824.9
349,124
388,537.9
351,807.6
Total Enterprise Value (TEV)
459,650.3
398,698.2
407,295.9
361,236
403,991.9
367,823.6
Dividend Yield
0.7%
0.9%
0.8%
Buyback Yield
0.5%
0.4%
Debt Paydown Yield
0%
-5.2%
-7.2%
-2.9%
-1.2%
1.3%
Shareholder Yield
-4.4%
-6.7%
-2.4%
-0.8%
1.8%
P/S
4.7
4
4.4
3.9
4.1
P/Gross Profit
5.7
5.9
P/E
17.3
16.3
18.2
25.1
26.5
9.6
Earnings Yield
5.8%
6.1%
5.5%
4%
3.8%
10.4%
P/OCF
17.9
15.9
14.4
15.5
14.3
P/FCF
22.1
19.8
19.3
17.6
18.7
FCF Yield
4.5%
5.1%
5.2%
5.7%
5.3%
P/B
5.5
5
4.9
EV/Sales
4.6
4.2
EV/Gross Profit
6.2
EV/EBITDA
12.8
4.3
12.4
EV/EBIT
17.4
16.4
EV/OCF
19
14.9
16.1
EV/FCF
23.5
21.5
20
19.5
18.1
Dividends
DPS
1.3
1.2
Payout Ratio
41.8%
56.5%
27.2%
88.4%
89.4%
63.7%
Margins
Gross Profit Margin
100%
67.9%
66.4%
68.3%
69.4%
Operating Margin
99.7%
28%
28.2%
15.9%
99.8%
EBITDA Margin
107.1%
36.2%
36.3%
24.3%
108%
35.9%
Net Profit Margin
31.2%
23.3%
50.2%
15.2%
14.9%
20.9%
Effective Tax Rate
—
14.7%
19.3%
11.7%
18.5%
Pre-Tax Profit Margin
27.3%
62.3%
17.3%
25.6%
Free Cash Flow Margin
33.4%
11.9%
15.4%
23.8%
31%
20.7%
OCF / Sales
38.2%
16.3%
19.1%
35.6%
25.1%
OCF / Net Income
122.4%
70%
37.9%
203.5%
239.5%
120.2%
FCF / OCF
87.4%
73.1%
81%
76.9%
87.1%
82.7%
FCF / Net Income
106.9%
51.2%
30.7%
156.5%
208.6%
99.4%
FCF / EBITDA
33%
42.5%
98%
28.7%
57.8%
Capital Efficiency
Return on Invested Capital
17%
3.9%
3.7%
2.5%
17.7%
3.6%
Return on Assets
12.9%
3%
2.7%
13%
Return on Equity
10%
7.4%
4.9%
4.7%
6.3%
Return on Total Capital
54.5%
11.5%
10.8%
8.8%
62.4%
Return on Capital Employed
17.8%
5%
4.8%
2.9%
18.1%
Return on Tangible Assets
7.9%
10.3%
3.5%
Receivables Turnover
1.4
1.5
Days Sales Outstanding
257
258.6
258.1
240.8
251.5
264.8
Payables Turnover
0.8
0.7
Days Payables Outstanding
438.1
439.5
510.6
512.5
Inventory Turnover
0.6
0.5
Days Inventory Outstanding
612
596.4
604.9
665.7
Cash Conversion Cycle
432.5
415
335.1
418
Asset Turnover
0.1
Fixed Asset Turnover
1.1
Operating Cycle
870.6
854.5
845.7
930.5
CapEx to OCF
0.3
0.2
CapEx to Revenue
0
CapEx to Depreciation
0.4
0.9
Financial Health
Total Debt
45,795
50,761
52,252
36,634
35,751
41,491
Net Debt
27,233
31,881
13,471
12,112
15,454
16,016
Current Ratio
1
Quick Ratio
Cash Ratio
Debt Ratio
Assets to Equity
2.4
2.5
Cash Flow to Debt Ratio
Long-term Debt to Assets
Intangibles to Total Assets
Net Current Asset Value
-58,928
-60,418
-44,011
-52,721
-54,880
-51,733
Goodwill / Assets
Debt / Equity
Total Debt / Capitalization
Long Term Debt / Capitalization
Long-Term Debt / Equity
Net Debt / EBITDA
3.7
1.7
2.2
2
EBIT / Interest Expense
21.6
30.3
-24.9
23.2
EBITDA / Interest Expense
27.9
39
-38
29.8
(EBITDA - Capex) / Interest Expense
24.5
35.1
-26.8
26.2
Per Share
Revenue per Share
9.9
9.8
9
9.3
Basic EPS
2.1
2.3
Diluted EPS
4.5
1.9
Book Value per Share
32.6
32.4
32.2
29.5
28.9
Tangible Book Value per Share
-7.2
-8.1
-1.3
-4.3
-5.8
-5.1
Cash per Share
7.6
7.8
16
10.1
8.4
10.5
Operating Cash Flow per Share
3.8
1.6
2.9
3.3
Free Cash Flow per Share
CapEx per Share
Weighted Avg. Shares Outstanding
2,408.3
2,406.3
2,407.2
2,427.1
Weighted Avg. Shares Outstanding Diluted
2,428.6
2,419.1
2,423.8
2,427.9
2,422
Common Size
R&D to Revenue
14.8%
23.5%
15.3%
SG&A to Revenue
24.8%
25.3%
Stock-based Comp to Revenue
1.4%
1.7%
1.1%
1.5%
